ApprovalTrail

Drug · DIN 02465167

MINT-FENOFIBRATE E

No: no longer authorized

The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.

Status Cancelled Post Market since April 28, 2020; first marketed September 29, 2017.
Drug Identification Number (DIN)
02465167
Company (DIN owner)
Mint Pharmaceuticals IncMississauga, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Fenofibrate C10AB05
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
FENOFIBRATE145 MG

Notices of Compliance

Health Canada approvals that name this DIN.